Just this summary on FN Arena:
Citi rates FNP as Buy (1) -
While the company's trading update disappointed many, judging by the share price response, Citi analysts see positives supporting their Buy rating. They've lifted the price target to $6.90 from $6.70.
The long term investment thesis remains intact and Citi analysts expect infant formula will compensate for growth reductions elsewhere. Estimates have fallen between -4-6% for FY18-19.
Target price is $6.90 Current Price is $5.94Difference: $0.96
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $37.40M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.5¢ | $3.941K | 29.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49254 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 77076 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| NOU (ASX) Chart |